1. United Kingdom Stocks

  2. •

    Technology services

  3. •

    Packaged software
Feedback plc

Feedback plc

LLSE:FDBK
6.65
GBX
-0.05
(-0.75%)
349.42MMarket Cap
Feb 23Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
0.01
0.4
0.42
0.4
0.36
0.34
0.18
0.06
0.06
0.08
0.09
0.03
- -
Basic EPS, GAAP
-0.53
-0.7
-1.16
-0.18
-0.23
-0.5
-0.58
-0.43
-0.32
-0.23
-0.22
-0.25
-0.25
- -
Free Cash Flow per Basic Share
- -
-0.72
-0.84
-0.21
-0.09
-0.39
-0.82
-0.66
-0.68
-0.17
-0.23
-0.26
-0.13
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
1.15
1.25
0.09
0.13
0.46
0.26
0.5
0.65
0.99
1.03
0.82
0.57
0.14
0.1
Tangible Book Value per Share
1.15
0.36
-0.05
0.02
0.39
0.15
0.26
0.17
0.48
0.78
0.54
0.27
0.13
0.09
Basic Weighted Avg Shares
1
1
1
1
1
1
2
3
5
9
13
13
29
44
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
1
- -
- -
1
1
1
1
- -
Operating Margin (%)
- -
-4,229.71
-117.3
-58.54
-64.59
-163.15
-201.01
-314.47
-716.78
-427
-333.85
-312.31
-475.43
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
1
1
- -
Net Income, GAAP
- -
- -
-1
- -
- -
-1
-1
-1
-2
-2
-3
-3
-7
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
-6,491.78
-290.97
-42.45
-57.1
-137.61
-172.82
-241.67
-563.48
-359.95
-284.7
-279.16
-826.25
- -
Working Capital
1
- -
- -
- -
- -
- -
1
- -
3
10
7
4
6
4
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
1
1
- -
- -
1
- -
1
2
5
14
11
8
6
4
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
-37.16
-48.03
-172.68
-167.75
-76.1
-134.97
-148.46
-80.11
-46.02
-22.33
-23.75
-35.63
-105.98
- -

Capital Structure

GBP

•

in mil. unless spec.
Nov'25
May'25
Nov'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
44
44
44
Market Capitalization
9
6
3

Working Capital

GBP

•

in mil. unless spec.
Nov'25
May'25
Nov'26
Total Current Assets
8
6
4
Cash, Cash Equivalents & STI
7
6
4
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

GBP

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
88.36%
57.65%
-19.36%
Free Cash Flow
59.52%
32.87%
3.45%
Net Income, GAAP
41.72%
50.47%
121.85%
Sales/Revenue/Turnover
15.51%
26.6%
-25.05%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
1
2025
- -
- -
1
2026
- -
- -
- -

Semi-annual Earnings Per Share

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.25
2025
- -
- -
-0.25
2026
- -
- -
- -

Semi-annual Dividends Per Share

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Thomas James Oakley
Full Time Employees
29
Sector
Technology services
Industry
Packaged software
Address
201 Temple Chambers London GL United Kingdom EC4Y 0DT
IPO Date
Jan 8, 1986
Website
fbk.com
Similar Companies
Microsoft Corporation (NASDAQ:MSFT)
Palantir Technologies Inc. (NASDAQ:PLTR)
Nebius Group N.V. (NASDAQ:NBIS)
Oracle Corporation (NYSE:ORCL)
CoreWeave, Inc. (NASDAQ:CRWV)
ServiceNow, Inc. (NYSE:NOW)
Business
Feedback plc (AIM: FDBK), a United Kingdom-based clinical infrastructure specialist incorporated in 1958 and headquartered at 201 Temple Chambers, 3-7 Temple Avenue, London EC4Y 0DT, develops and provides innovative software and systems through its trading subsidiary Feedback Medical to enhance clinician access to patient data and collaboration across care settings. The company's core products include Bleepa, a UKCA-marked, regulated communication and collaboration platform that displays clinical-grade medical images and results to enable multidisciplinary team working, diagnostic-enhanced advice and guidance, and secure auditable chat linked to patient records; CareLocker, a patient-facing cloud-based data layer that provides secure access, control, and portability of diagnostic and clinical data; legacy imaging solutions such as Cadran, a picture archiving, storage, management, and display system for medical images; and TexRAD, a patented texture analysis algorithm including TexRAD Lung for lung cancer analysis; as well as Bleepa Box for sharing DICOM images over mobile networks. Feedback operates primarily in the UK National Health Service (NHS) market with expansion into private healthcare providers, community diagnostic centres, and international opportunities including India via Feedback Medical India Limited, targeting public and private sectors with a scalable software-as-a-service model focused on streamlining patient pathways, reducing elective waitlists, and supporting digitisation initiatives. Recent developments include a £495k contract with Queen Victoria Hospital NHS Foundation Trust for digital infrastructure and extension of its community diagnostic centre pilot at Northern Care Alliance NHS Foundation Trust; a £6.1m gross equity fundraise in November 2024 via placing, subscription, and retail offer to support growth; Bleepa reimbursement approval under the NHS Elective Recovery Fund for diagnostic-enhanced advice and guidance; integrations with NHS referral systems including PDS, GP Connect, and eRS for scalability; partnerships such as a collaboration with Vertex In Healthcare to broaden functionality and global reach, a memorandum of understanding with a leading UK primary care provider and NHS Trust for a Neighbourhood Diagnostics Solution pilot, and an implementation agreement with Moorhouse Consulting; post-period operationalisation of revenue-generating projects in India including a pilot with a large Asian hospital group and a tuberculosis screening programme with HEAL Foundation; and establishment of an External Affairs department aligned with NHS 2025/26 priorities for elective care recovery and community-based care.